March 24, 2009 - Efficacy and safety study results for Corthera's investigational drug relaxin for the treatment of acute heart failure (AHF) will be presented Sunday, March 29, during the American College of Cardiology's (ACC) 58th Annual Scientific Session in Orlando, FL.
